Xi-idra

lifitegrast · Shire (acquired by Takeda)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xi-idra, covering 2019-05-17 to 2023-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra [Phase 4]